40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
Why Pfizer Shares Are Trading Higher Today
Pfizer Inc (NYSE: PFE) is trading higher Monday after UBS upgraded the stock and raised its price target.
UBS analyst Colin Bristow upgraded Pfizer from a Neutral rating to a Buy rating and raised the price target from $52 to $60.
Why Arena Pharmaceuticals Stock Is Soaring Today
Arena Pharmaceuticals Inc (NASDAQ: ARNA) is soaring Monday morning after Pfizer Inc (NYSE: PFE) announced it would acquire the company for $100 per share.
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48.
Pfizer To Acquire Arena Pharmaceuticals For $100/Share In Cash
On December 12, 2021, Arena entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Pfizer Inc., a Delaware corporation (“Parent”), and Antioch Merger Sub, Inc., a Delaware
Wells Fargo Initiates Coverage On Arena Pharmaceuticals with Overweight Rating, Announces Price Target of $71
Wells Fargo analyst Derek Archila initiates coverage on Arena Pharmaceuticals (NASDAQ:ARNA) with a Overweight rating and announces Price Target of $71.
Chart: How Have Cannabis Industry Sectors Performed This Year And What Are Their Valuation Multiples? Do They Make Sense?
Viridian Capital Advisors breaks the cannabis industry down into 12 sub sectors for purposes of tracking capital raises, M&A activity, valuation, and credit analysis by industry sector.